The Effect of Guided Narrative Technique on Child Post-traumatic Stress Symptoms Related to Teachers' Improper Criticism

June 8, 2022 updated by: YinyinZang, Peking University

The Effect of Guided Narrative Technique on Child Post-traumatic Stress Symptoms Related to Teachers' Improper Criticism: A Cluster Randomized Controlled Trial

Teachers' improper criticism may lead to posttraumatic stress symptoms (PTSS) in children. This cluster randomized controlled trial examined the effect of guided narrative technique (GNT) on child PTSS caused by teachers' improper criticism in school settings.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Peking University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 5th grade students
  • 7-13 years old
  • with the ability to read and write

Exclusion Criteria:

  • younger than 7 years old or older than 13 years old
  • having psychotic disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Treatment group
The experimental group underwent the psychological intervention of guided narrative technique-writing with the theme of teacher criticism for 20 to 30 minutes once a day for three consecutive days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change from baseline child posttraumatic stress symptoms at posttreatment
Time Frame: 1 week

Foa et al.,(2018) revised the Self-Rating Scale for Symptoms of Post-traumatic Stress Disorder in Children (CPSS-5-SR), with Cronbach's α reliability coefficient of 0.78.

Cpss-5-SR is a 27-item self-reporting measure. Symptom items were scored on a 5-point scale, ranging from 0 (not at all) to 4 (almost always).

1 week
change from baseline child posttraumatic stress symptoms at follow-up
Time Frame: 6 months

Foa et al.,(2018) revised the Self-Rating Scale for Symptoms of Post-traumatic Stress Disorder in Children (CPSS-5-SR), with Cronbach's α reliability coefficient of 0.78.

Cpss-5-SR is a 27-item self-reporting measure. Symptom items were scored on a 5-point scale, ranging from 0 (not at all) to 4 (almost always).

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

May 30, 2022

First Submitted That Met QC Criteria

June 8, 2022

First Posted (Actual)

June 13, 2022

Study Record Updates

Last Update Posted (Actual)

June 13, 2022

Last Update Submitted That Met QC Criteria

June 8, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Posttraumatic Stress Symptoms

Clinical Trials on guided narrative technique-writing

3
Subscribe